Breast cancer survivors with severe menopausal symptoms should be supported to make an informed decision about whether to have hormone replacement therapy or not, according to an interdisciplinary ...
In the article that accompanies this editorial, Dumas et al 12 modeled the potential improvements in 5-year disease-free survival (DFS) from hormone receptor–positive early-stage breast cancer if ...
Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, but regimen-specific effects dominated the aggregate estimate.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results